US COVID-19 Fraud: IV Drip Provider Reconsiders Claims, Bee Honey Joins List Of Unapproved Cures
Executive Summary
New York business reconsiders claiming intravenous drips of vitamin blends prevent COVID-19 infections after industry group forwarded concerns to regulators. Latest natural health remedy linked to fraudulent COVID-19 treatment claims is honey from marketers’ beehives.
You may also be interested in...
US COVID-19 Fraud: Avenova Eyelid, Eyelash Cleanser Spray Latest Target Of FDA, FTC Warning
Federal agencies submitted joint warning to NovaBay after reviewing its website and social media pages for its Avenova (hypochlorous acid 0.01%) spray solution.
US FDA’s 30-Day Extension For Nitrosamine Assessments Short Of Industry Recommendation
Revision to FDA's September 2020 guidance on assessing nitrosamine impurity risks associated with all chemically synthesized APIs and all approved drug products that contain those APIs doesn’t satisfy industry stakeholders.
With Timetable In Hand And Icahn On Board, Bausch Health Looks To ‘Expedite Spin-Off’
Executives say Bausch + Lomb spin-out preparations will be completed by the end of Q3. When asked, they elaborated on Carl Icahn’s acquisition of 27.8m shares, for a 7.8% stake, and expansion of the firm’s board by two seats for Icahn’s representatives.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: